<DOC>
	<DOCNO>NCT01594866</DOCNO>
	<brief_summary>The purpose study evaluation remission rate escitalopram 20 mg 30 mg patient major depressive disorder .</brief_summary>
	<brief_title>Lexapro® 's Efficacy After Dose Escalation Remission Study</brief_title>
	<detailed_description>In study , investigator go examine efficacy escitalopram dose escalation evaluate remission rate . This study design double-blinded 6-week prospective study . It would useful clinician study high-dose antidepressant treatment lack remission major depressive disorder patient . To control bias , investigator include patient lack remission 4-week escitalopram treatment .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Age : 18 ~ 65 Patient major depressive disorder accord DSMIV criterion Patient sign informed consent , well understood objective procedure study . MADRS total score ≥ 18 Competent patient manage answer questionnaire . In case female childbearing age , consent use appropriate contraceptive method ( oral pill , contraceptive injection , intrauterine device , double barrier method contraceptive patch ) entire duration study . In previous depressive episode , efficacy although one antidepressant treatment Allergy hypersensitivity escitalopram Diagnosed schizophrenia bipolar disorder schizoaffective disorder ( DSMIV ) MADRS 10 score ≥ 5 , patient suppose impossible participate study due clinical risk suicide aggressive behavior base clinician 's opinion Pregnant breastfeed female patient Significant biochemical hematological abnormality abnormal finding urinalysis , base clinician 's opinion Significant severe medical condition Patients take antipsychotic mood stabilizer psychiatric drug exclude benzodiazepine beta blocker hypnotic History participate investigational drug trial within 1month prior screen Investigator employee clinical trial center , personnel relate investigator trial center study , family employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Major depressive disorder , remission , escitalopram</keyword>
</DOC>